447 related articles for article (PubMed ID: 11313917)
21. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
[TBL] [Abstract][Full Text] [Related]
22. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
[TBL] [Abstract][Full Text] [Related]
24. New Myc-interacting proteins: a second Myc network emerges.
Sakamuro D; Prendergast GC
Oncogene; 1999 May; 18(19):2942-54. PubMed ID: 10378691
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
[TBL] [Abstract][Full Text] [Related]
26. p27kip1-independent cell cycle regulation by MYC.
Berns K; Martins C; Dannenberg JH; Berns A; te Riele H; Bernards R
Oncogene; 2000 Oct; 19(42):4822-7. PubMed ID: 11039898
[TBL] [Abstract][Full Text] [Related]
27. c-Myc does not require max for transcriptional activity in PC-12 cells.
Ribon V; Leff T; Saltiel AR
Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
[TBL] [Abstract][Full Text] [Related]
28. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Petrovas C; Jeay S; Lewis RE; Sonenshein GE
Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
[TBL] [Abstract][Full Text] [Related]
29. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
Popov N; Wahlström T; Hurlin PJ; Henriksson M
Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
[TBL] [Abstract][Full Text] [Related]
30. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
[TBL] [Abstract][Full Text] [Related]
31. Repression by the Mad(Mxi1)-Sin3 complex.
Schreiber-Agus N; DePinho RA
Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27.
Leshem Y; Spicer DB; Gal-Levi R; Halevy O
J Cell Physiol; 2000 Jul; 184(1):101-9. PubMed ID: 10825239
[TBL] [Abstract][Full Text] [Related]
33. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels.
Chandramohan V; Jeay S; Pianetti S; Sonenshein GE
J Immunol; 2004 May; 172(9):5522-7. PubMed ID: 15100294
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
Larsson LG; Bahram F; Burkhardt H; Lüscher B
Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).
Williamson EA; Dadmanesh F; Koeffler HP
Oncogene; 2002 May; 21(20):3199-206. PubMed ID: 12082635
[TBL] [Abstract][Full Text] [Related]
39. c-Myc inhibits CD11a and CD11c leukocyte integrin promoters.
López-Rodríguez C; Delgado MD; Puig-Kröger A; Nueda A; Muñoz E; León J; Bernabéu C; Corbi AL
Eur J Immunol; 2000 Sep; 30(9):2465-71. PubMed ID: 11009078
[TBL] [Abstract][Full Text] [Related]
40. c-Myc inactivation by mutant Max alters growth and morphology of NCI-H-630 colon cancer cells.
Borrè A; Cultraro CM; Segal S
J Cell Physiol; 1996 Oct; 169(1):200-8. PubMed ID: 8841436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
